{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:51:46Z","timestamp":1793681506560,"version":"4.5.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20Z11900303"],"award-info":[{"award-number":["20Z11900303"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018920","name":"Ruijin Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020732","name":"Innovative Research Team of High-level Local Universities in Shanghai","doi-asserted-by":"publisher","award":["SHSMU-ZDCX20211801"],"award-info":[{"award-number":["SHSMU-ZDCX20211801"]}],"id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.labinv.2025.104181","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T19:01:56Z","timestamp":1745866916000},"page":"104181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nuclear Receptor\u2013Binding SU(VAR)3-9, Enhancer of Zeste, Trithorax Domain Structural Domain Protein 2 Serves as a Potential Prognostic Biomarker in Mantle Cell Lymphoma"],"prefix":"10.1016","volume":"105","author":[{"given":"Yu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binshen","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5956-9328","authenticated-orcid":false,"given":"Chaofu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.labinv.2025.104181_bib1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.labinv.2025.104181_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/path.1711630104","article-title":"Translocation (11;14): a cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage","volume":"163","author":"Vandenberghe","year":"1991","journal-title":"J Pathol"},{"issue":"5","key":"10.1016\/j.labinv.2025.104181_bib3","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0002-9440(10)65399-0","article-title":"Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization","volume":"154","author":"Li","year":"1999","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.labinv.2025.104181_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.semdp.2017.11.001","article-title":"In situ neoplasia in lymph node pathology","volume":"35","author":"Oishi","year":"2018","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"10.1016\/j.labinv.2025.104181_bib5","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fern\u00e0ndez","year":"2010","journal-title":"Cancer Res"},{"issue":"24","key":"10.1016\/j.labinv.2025.104181_bib6","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1182\/bloodadvances.2023010757","article-title":"Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma","volume":"7","author":"Gerson","year":"2023","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.labinv.2025.104181_bib7","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood.2020005289","article-title":"Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes","volume":"136","author":"Nadeu","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.labinv.2025.104181_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153283","article-title":"Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma","volume":"132","author":"Yi","year":"2022","journal-title":"J Clin Invest"},{"issue":"15","key":"10.1016\/j.labinv.2025.104181_bib9","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1200\/JCO.2016.70.7901","article-title":"New molecular assay for the proliferation signature in mantle cell lymphoma applicable to formalin-fixed paraffin-embedded biopsies","volume":"35","author":"Scott","year":"2017","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.labinv.2025.104181_bib10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.labinv.2025.104181_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41408-019-0209-5","article-title":"Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse","volume":"9","author":"Kumar","year":"2019","journal-title":"Blood Cancer J"},{"issue":"4","key":"10.1016\/j.labinv.2025.104181_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.molcel.2011.08.042","article-title":"NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming","volume":"44","author":"Kuo","year":"2011","journal-title":"Mol Cell"},{"issue":"11","key":"10.1016\/j.labinv.2025.104181_bib13","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/ng.2777","article-title":"Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia","volume":"45","author":"Jaffe","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.labinv.2025.104181_bib14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1158\/2159-8290.CD-20-1771","article-title":"PRC2 inhibitors overcome glucocorticoid resistance driven by NSD2 mutation in pediatric acute lymphoblastic leukemia","volume":"12","author":"Li","year":"2022","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1016\/j.labinv.2025.104181_bib15","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood-2007-05-088674","article-title":"The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity","volume":"111","author":"Lauring","year":"2008","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.labinv.2025.104181_bib16","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1016\/j.molcel.2021.08.034","article-title":"NSD2 dimethylation at H3K36 promotes lung adenocarcinoma pathogenesis","volume":"81","author":"Sengupta","year":"2021","journal-title":"Mol Cell"},{"issue":"7","key":"10.1016\/j.labinv.2025.104181_bib17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/cr.2014.71","article-title":"An epigenomic approach to therapy for tamoxifen-resistant breast cancer","volume":"24","author":"Feng","year":"2014","journal-title":"Cell Res"},{"issue":"9","key":"10.1016\/j.labinv.2025.104181_bib18","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1158\/1078-0432.CCR-10-1302","article-title":"The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors","volume":"17","author":"Hudlebusch","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.labinv.2025.104181_bib19","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1158\/0008-5472.CAN-10-3810","article-title":"MMSET is highly expressed and associated with aggressiveness in neuroblastoma","volume":"71","author":"Hudlebusch","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.labinv.2025.104181_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111471","article-title":"Histone methyltransferase WHSC1 cooperate with YBX1 promote glioblastoma progression via regulating PLK1 expression","volume":"124","author":"Lu","year":"2024","journal-title":"Cell Signal"},{"issue":"9","key":"10.1016\/j.labinv.2025.104181_bib21","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1096\/fj.201601140RR","article-title":"MiR-2392 suppresses metastasis and epithelial\u2013mesenchymal transition by targeting MAML3 and WHSC1 in gastric cancer","volume":"31","author":"Li","year":"2017","journal-title":"FASEB J"},{"issue":"52","key":"10.1016\/j.labinv.2025.104181_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2305684120","article-title":"Tiam1 methylation by NSD2 promotes Rac1 signaling activation and colon cancer metastasis","volume":"120","author":"Song","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.labinv.2025.104181_bib23","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1038\/s41467-018-07511-4","article-title":"NSD2 is a conserved driver of metastatic prostate cancer progression","volume":"9","author":"Aytes","year":"2018","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.labinv.2025.104181_bib24","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/s41588-024-01893-6","article-title":"NSD2 is a requisite subunit of the AR\/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis","volume":"56","author":"Parolia","year":"2024","journal-title":"Nat Genet"},{"issue":"13","key":"10.1016\/j.labinv.2025.104181_bib25","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1182\/bloodadvances.2019001350","article-title":"Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis","volume":"4","author":"Hill","year":"2020","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.labinv.2025.104181_bib26","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1038\/s41375-023-01977-y","article-title":"Clinical outcome of mantle cell lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression)","volume":"37","author":"Scheubeck","year":"2023","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.labinv.2025.104181_bib27","first-page":"1171","article-title":"MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53\/p53\u2014a Nordic Lymphoma Group study","volume":"109","author":"Rodrigues","year":"2024","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.labinv.2025.104181_bib28","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1200\/JCO.2015.63.8387","article-title":"Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European Mantle Cell Lymphoma Network","volume":"34","author":"Hoster","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.labinv.2025.104181_bib29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13045-023-01520-7","article-title":"Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium","volume":"16","author":"Vose","year":"2023","journal-title":"J Hematol Oncol"},{"issue":"4","key":"10.1016\/j.labinv.2025.104181_bib30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood-2017-07-797019","article-title":"Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network","volume":"131","author":"Aukema","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.labinv.2025.104181_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"269","key":"10.1016\/j.labinv.2025.104181_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"2","key":"10.1016\/j.labinv.2025.104181_bib33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.labinv.2025.104181_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/leu.2013.204","article-title":"Point mutation E1099K in MMSET\/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies","volume":"28","author":"Oyer","year":"2014","journal-title":"Leukemia"},{"issue":"7846","key":"10.1016\/j.labinv.2025.104181_bib35","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41586-020-03069-8","article-title":"Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases","volume":"590","author":"Li","year":"2021","journal-title":"Nature"},{"issue":"34","key":"10.1016\/j.labinv.2025.104181_bib36","doi-asserted-by":"crossref","first-page":"13549","DOI":"10.1073\/pnas.1205707109","article-title":"Total kinetic analysis reveals how combinatorial methylation patterns are established on lysines 27 and 36 of histone H3","volume":"109","author":"Zheng","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.labinv.2025.104181_bib37","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/s41379-021-00885-9","article-title":"EZH2 expression is associated with inferior overall survival in mantle cell lymphoma","volume":"34","author":"Martinez-Baquero","year":"2021","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.labinv.2025.104181_bib38","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ajh.26523","article-title":"Mantle cell lymphoma in 2022-A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments","volume":"97","author":"Jain","year":"2022","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.labinv.2025.104181_bib39","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/cas.14069","article-title":"Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target?","volume":"110","author":"Ohue","year":"2019","journal-title":"Cancer Sci"},{"issue":"22","key":"10.1016\/j.labinv.2025.104181_bib40","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1182\/blood.2020010527","article-title":"SOX11, CD70, and Treg cells configure the tumor-immune microenvironment of aggressive mantle cell lymphoma","volume":"138","author":"Balsas","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.labinv.2025.104181_bib41","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood-2006-10-053793","article-title":"Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse","volume":"110","author":"Reichardt","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.labinv.2025.104181_bib42","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.trecan.2024.07.009","article-title":"CD4+ T cells in antitumor immunity","volume":"10","author":"Montauti","year":"2024","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.labinv.2025.104181_bib43","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/blood-2002-12-3665","article-title":"\u03b3\u03b4 T cells for immune therapy of patients with lymphoid malignancies","volume":"102","author":"Wilhelm","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.labinv.2025.104181_bib44","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.7150\/thno.54546","article-title":"Peripheral eosinophil counts predict efficacy of anti-CD19 CAR-T cell therapy against B-lineage non-Hodgkin lymphoma","volume":"11","author":"Jia","year":"2021","journal-title":"Theranostics"},{"issue":"18","key":"10.1016\/j.labinv.2025.104181_bib45","doi-asserted-by":"crossref","first-page":"16056","DOI":"10.1021\/acs.jmedchem.4c00639","article-title":"Discovery of a highly potent and selective inhibitor targeting protein lysine methyltransferase NSD2","volume":"67","author":"Wei","year":"2024","journal-title":"J Med Chem"},{"issue":"16","key":"10.1016\/j.labinv.2025.104181_bib46","doi-asserted-by":"crossref","first-page":"10991","DOI":"10.1021\/acs.jmedchem.3c00948","article-title":"Drug discovery targeting nuclear receptor binding SET domain protein 2 (NSD2)","volume":"66","author":"Ma","year":"2023","journal-title":"J Med Chem"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725000911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725000911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T14:48:28Z","timestamp":1755614908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683725000911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0023683725000911"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104181","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nuclear Receptor\u2013Binding SU(VAR)3-9, Enhancer of Zeste, Trithorax Domain Structural Domain Protein 2 Serves as a Potential Prognostic Biomarker in Mantle Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104181"}}